Imaging of deep venous thrombosis using radioactive-labeled tirofiban

Bratislava Medical Journal

Volumn 116, Issue 10, 2015, Pages 621-626

  Darkovska Serafimovska, M ^a   Janevik Ivanovska, E ^a   Ugresic, N ^c   Djorgoski, I ^b  

^a GOCE DELCEV UNIVERSITY   (Macedonia)

^b SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Deep venous thrombosis; 99mTc tirofiban; Imaging; Radionuclide labeling; Rat model

Indexed keywords

FIBRINOGEN RECEPTOR; TECHNETIUM; TIROFIBAN; TYROSINE;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; MALE; RAT; SCINTISCANNING; VEIN THROMBOSIS; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RATS; RATS, WISTAR; TECHNETIUM; TYROSINE; VENOUS THROMBOSIS;

EID: 84973402338     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2015_120     Document Type: Article

References (25)

1. Hyers TM. Venous thromboembolism. Am J Resp Crit Care Med 1999; 159: 1-14.
2. Horlander KT, Mannino DM, Leeper KV. Pulmonary mortality in the United States, 1979-1998. Arch Intern Med 2003; 163: 1711-1721.
3. Medicure Pharma. Aggrastat (Tirofiban hydrochloride) injection premixed and injection prescribing information. Somerset, NJ; 2007 Nov.
4. Tirofiban hydrochloride. Drugs Future 1995; 20: 897-901.
5. Aruva MR, Daviau J, Sharma SS, Thakur ML. Imaging Thromboembolism with Fibrin-Avid 99mTc-Peptide: Evaluation in Swine. J Nucl Med 2006; 47 (1): 155-162.
6. Knight LC, Radcliffe R, Maurer AH et al. Thrombus imaging with 99mTc synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets. J Nucl Med 1994; 35: 282-288.
7. Knight LC, Maurer AH, Romano JE. Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model. J Nucl Med 1996; 37: 476-482.
8. Pearson DA, Lister-James J, McBride WJ et al. Thrombus imaging using 99mTc labeled high potency GPIIb./IIIa receptor antagonist: chemistry and initial biological studies. J Med Chem 1990; 39: 1372-1382.
9. Lister-James J, Vallabhajosula S, Moyer BR et al. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide. J Nucl Med 1997; 38: 105-111.
10. Line BR, Cran P, Lazewatsky J et al. Phase I trial of DMP444, a new thrombus imaging agent (abstract). J Nucl Med 1996; 37 (Suppl): 117P.
11. Barrett JA, Damphousse DJ, Heminway SJ et al. Biological evaluation of 99mTc cyclic glycoprotein IIb/IIIa receptor antagonists in the canine anteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of (99mTc) chelator-peptide conjugates. Bioconjug Chem 1996; 7: 203-208.
12. Coller BS. Cell adhesion in vascular biology: Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics. J Clin Invest 1997; 99: 1467-1471.
13. Verstraete M. Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development. Circulation 2000; 102: e76-e80.
14. Weiss DJ et al. Platelet kinetics in dogs treated with a glycoprotein IIb/IIIapeptide antagonist. Toxicol Pathol 2000; 28: 310-316.
15. ICH Topic Q 2 (R1) Note for guidance on validation of analytical procedures: Text and methodology (CPMP/ICH/381/95), European Medicines Agency, London, 1995.
16. Ranjitha KS, Rao AL. Development and validation of new RP-HPLC method for determination of Tirofiban in pharmaceutical formulation. IJPCBC 2011; 1 (1): 43-47.
17. th of July, 2012.
18. Callas JW, Fareed DDJ. A survey of animal models to develop new and novel antithrombotic agents. In: Sasahara AA, Loscalzo JL (Eds). New Therapeutic Agents in Thrombosis and Thrombolysis 1997; 9-28.
19. Herbert JM, Bernat A, Maffrand JP. Importance of platelets in experimental venous thrombosis in the rat. Blood 1992; 80: (9): 2281-2286.
20. Lister-James J, Mauer A. Thrombus imaging with a technetium 99mlabeled, activated platelet receptor binding peptide. J Nucl Med 1996; 213: 207.
21. Olfert ED, Cross BM, McWilliam AA (Eds). Guide to the care and use of experimental animals. Canad Council Anim Care 1993; 1.
22. Stassen JM. Animal model to assess the safety and efficacy of thrombolytic agents. New Therapeutic Agents in Thrombosis and Thrombolysis. In: Sasahara AA, Loscalzo JL (Eds). New Therapeutic Agents in Thrombosis and Thrombolysis 1997; 451-474.
23. Zhou Y, Chakraborty S, Liu S. Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT. Theranostics 2011; 1: 58-82.
24. Carretta RF, Streek PV, Weiland FL. Optimizing Images of Acute Deep-Vein Thrombosis Using Technetium-99m-Apcitide. J Nucl Med Techn 1999; 27: 271-275.
25. Houshmand S, Salavati1 A, Hess S, Ravina M, Alavi A. The role of molecular imaging in diagnosis of deep vein thrombosis. Am J Nucl Med Mol Imaging 2014; 4 (5): 406-425.